Hemogenyx Pharmaceuticals Plc (HOPHF)
USD 1.24
(0.0%)
USD 1.24
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -645.68 Thousand GBP | 75.16% |
| 2022 | -2.59 Million GBP | -816.55% |
| 2021 | -283.64 Thousand GBP | 19.12% |
| 2020 | -350.71 Thousand GBP | 16.86% |
| 2019 | -421.81 Thousand GBP | -21.12% |
| 2018 | -348.26 Thousand GBP | -246.6% |
| 2017 | -100.48 Thousand GBP | -50.3% |
| 2016 | -66.85 Thousand GBP | -1076.64% |
| 2015 | 6845.42 GBP | 0.0% |
| 2014 | - GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - GBP | 0.0% |
| 2024 Q1 | - GBP | 100.0% |
| 2023 Q3 | - GBP | 100.0% |
| 2023 FY | -645.68 Thousand GBP | 75.16% |
| 2023 Q4 | -325.77 Thousand GBP | 0.0% |
| 2023 Q2 | -319.9 Thousand GBP | 0.0% |
| 2023 Q1 | - GBP | 100.0% |
| 2022 Q1 | - GBP | 100.0% |
| 2022 FY | -2.59 Million GBP | -816.55% |
| 2022 Q3 | - GBP | 100.0% |
| 2022 Q4 | -531.83 Thousand GBP | 0.0% |
| 2022 Q2 | -32.23 Thousand GBP | 0.0% |
| 2021 Q1 | - GBP | 100.0% |
| 2021 FY | -283.64 Thousand GBP | 19.12% |
| 2021 Q4 | -64.16 Thousand GBP | 0.0% |
| 2021 Q3 | - GBP | 100.0% |
| 2021 Q2 | -62.17 Thousand GBP | 0.0% |
| 2020 Q3 | - GBP | 100.0% |
| 2020 Q2 | -48.56 Thousand GBP | 0.0% |
| 2020 Q4 | -58.18 Thousand GBP | 0.0% |
| 2020 Q1 | - GBP | 100.0% |
| 2020 FY | -350.71 Thousand GBP | 16.86% |
| 2019 FY | -421.81 Thousand GBP | -21.12% |
| 2019 Q4 | -67.17 Thousand GBP | 0.0% |
| 2019 Q3 | - GBP | 100.0% |
| 2019 Q2 | -27.55 Thousand GBP | 0.0% |
| 2019 Q1 | - GBP | 0.0% |
| 2018 Q3 | - GBP | 0.0% |
| 2018 Q2 | - GBP | 0.0% |
| 2018 Q4 | - GBP | 0.0% |
| 2018 Q1 | - GBP | 0.0% |
| 2018 FY | -348.26 Thousand GBP | -246.6% |
| 2017 Q4 | - GBP | 0.0% |
| 2017 FY | -100.48 Thousand GBP | -50.3% |
| 2017 Q1 | - GBP | 0.0% |
| 2017 Q3 | - GBP | 0.0% |
| 2017 Q2 | - GBP | 0.0% |
| 2016 FY | -66.85 Thousand GBP | -1076.64% |
| 2015 FY | 6845.42 GBP | 0.0% |
| 2014 FY | - GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 104.305% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 20914.99% |
| SQZ Biotechnologies Company | 9.79 Million USD | 106.593% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 105.516% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.542% |
| Mesoblast Limited | -35.16 Million USD | 98.164% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -1790.72% |
| Genus plc | 178.7 Million USD | 100.361% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 257.42% |
| Marizyme, Inc. | 457.7 Thousand USD | 241.07% |
| ContraFect Corporation | -154 Thousand USD | -319.273% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -5769.827% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -1191.362% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 941.158% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 1082.353% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -66.627% |
| MultiCell Technologies, Inc. | 49.32 USD | 1309266.667% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 101.604% |
| EV Biologics, Inc. | 48.9 Thousand USD | 1420.411% |
| Q BioMed Inc. | -8988.00 USD | -7083.812% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 102.285% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -4086.21% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.293% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 1022.401% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -419.659% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 1137.639% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -12938.792% |
| Arch Therapeutics, Inc. | -2439.00 USD | -26373.186% |
| IMV Inc. | -962.29 Thousand USD | 32.902% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 559.559% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -562.135% |
| GB Sciences, Inc. | -624.00 USD | -103374.519% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -650.547% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.009% |
| Halberd Corporation | -208.00 USD | -310323.558% |
| Enzolytics Inc. | 30.7 Thousand USD | 2202.648% |
| Resverlogix Corp. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 147.576% |
| SYBLEU INC | 11.69 Thousand USD | 5620.528% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 233.838% |
| argenx SE | 1.1 Billion USD | 100.058% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 97.497% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 204.583% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.158% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -7190.888% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 101.456% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 43.439% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 165.354% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 106.718% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -670.052% |
| BioStem Technologies, Inc. | 15.42 Million USD | 104.186% |
| ONE Bio Corp. | 20.12 Million USD | 103.208% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Agentix Corp. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -5355.691% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -1237.949% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 465.701% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 465.701% |
| NovAccess Global Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -25.494% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | -2.467% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -2126.486% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 243.471% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -102.087% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 114.012% |
| Bioxytran, Inc. | -8285.00 USD | -7693.374% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -73.105% |
| Neutra Corp. | 14.33 Thousand USD | 4604.227% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -687.416% |
| PureTech Health plc | -1.6 Million USD | 59.72% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 35.512% |
| IXICO plc | 3.27 Million USD | 119.746% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 6.962% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 63.949% |
| CSL Limited | 7.7 Billion USD | 100.008% |
| Cellectis S.A. | 18 Thousand USD | 3687.117% |